Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday.
By Mill Chart
Last update: May 1, 2024
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.
Gainers
| Ticker | Change | Comment |
|---|---|---|
| TECH | 17.32% | BIO-TECHNE CORP's (NASDAQ:TECH) shares rose 17.32% to $74.16 during Wednesday's session. yesterday the company released their earnings. In the last year the share price dropped with 23.96%. |
| GRMN | 13.38% | In an impressive move, GARMIN LTD's (NYSE:GRMN) shares recorded a 13.38% increase, closing at $163.79 during Wednesday's session. GARMIN LTD released earnings Yesterday. Shareholders saw the stock price going 24.96% higher is the past 6 months. |
| AMCR | 10.74% | Positive market sentiment drove AMCOR PLC's (NYSE:AMCR) stock price up by 10.74% to $9.9 during Wednesday's session. |
| DD | 8.04% | With a 8.04% surge, DUPONT DE NEMOURS INC's (NYSE:DD) stock price reached $78.33 during Wednesday's session, signaling positive momentum. The company's earnings where released Yesterday. |
| VRSK | 7.76% | VERISK ANALYTICS INC (NASDAQ:VRSK) witnessed a notable 7.76% uptick in its shares, reaching $234.87 during Wednesday's session. The company's earnings where released Yesterday. A press release (Verisk Reports First-Quarter 2024 Financial Results) was released earlier today. |
| PFE | 7.03% | Investors witnessed a remarkable 7.03% rise in PFIZER INC's (NYSE:PFE) shares, which climbed to $27.42 during Wednesday's session. yesterday the company released their earnings. Yesterday the company had a press release: Pfizer Reports First-Quarter 2024 Results. |
| PARA | 6.1% | PARAMOUNT GLOBAL-CLASS B's (NASDAQ:PARA) stock price increased by 6.1% to $12.09. In the last 3 months the stock lost 21.07%. |
| HUM | 5.62% | Investors celebrated as HUMANA INC (NYSE:HUM) experienced a 5.62% rise in its shares, closing at $319.07 during Wednesday's session. The stock is trading 20.27% lower than 3 months ago. |
| WBD | 5.03% | Investors celebrated as WARNER BROS DISCOVERY INC (NASDAQ:WBD) experienced a 5.03% rise in its shares, closing at $7.73 during Wednesday's session. In the last 3 months the stock lost 28.2%. |
| JNJ | 4.92% | JOHNSON & JOHNSON's (NYSE:JNJ) shares rose 4.92% to $151.7. Yesterday the company had a press release: Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization. |
To see the full list of top gainers you can use our top gainers page.
Top losers
| Ticker | Change | Comment |
|---|---|---|
| SBUX | -17.28% | STARBUCKS CORP (NASDAQ:SBUX) encountered a 17.28% decrease in its shares, reaching $73.19 during Wednesday's session. A press release (Starbucks Reports Q2 Fiscal 2024 Results) was released yesterday. |
| CVS | -17.19% | The market experienced a 17.19% downturn in CVS HEALTH CORP's (NYSE:CVS) stock price, closing at $56.07 during Wednesday's session. CVS HEALTH CORP released earnings Yesterday. Yesterday the company had a press release: CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?. |
| SWKS | -13.2% | There was a downturn in SKYWORKS SOLUTIONS INC's (NASDAQ:SWKS) shares, as they experienced a 13.2% decline, closing at $92.52 during Wednesday's session. A press release (Skyworks Reports Q2 FY24 Results) was released yesterday. |
| NCLH | -12.89% | NORWEGIAN CRUISE LINE HOLDIN's (NYSE:NCLH) shares fell 12.89% to $16.48 during Wednesday's session. NORWEGIAN CRUISE LINE HOLDIN released earnings Yesterday. In the last 6 months the share price increased with 37.0%. |
| SMCI | -11.06% | Investors witnessed a 11.06% drop in SUPER MICRO COMPUTER INC's (NASDAQ:SMCI) stock price, which closed at $763.78 during Wednesday's session. Yesterday the company had a press release: Supermicro Announces Third Quarter Fiscal Year 2024 Financial Results. |
| EL | -10.9% | There was a downturn in ESTEE LAUDER COMPANIES-CL A's (NYSE:EL) shares, as they experienced a 10.9% decline, closing at $130.72 during Wednesday's session. yesterday the company released their earnings. In the last 6 months the share price increased with 32.22%. |
| GPN | -9.99% | GLOBAL PAYMENTS INC's (NYSE:GPN) shares fell 9.99% to $110.51 during Wednesday's session. GLOBAL PAYMENTS INC released earnings Yesterday. Yesterday the company had a press release: Global Payments Reports First Quarter 2024 Results. |
| CDW | -9.56% | The market experienced a 9.56% downturn in CDW CORP/DE's (NASDAQ:CDW) stock price, closing at $218.74 during Wednesday's session. CDW CORP/DE released earnings Yesterday. Yesterday the company had a press release: CDW Declares Quarterly Cash Dividend of $0.62 Per Share. |
| AMD | -7.56% | Investors witnessed a 7.56% decrease in ADVANCED MICRO DEVICES's (NASDAQ:AMD) stock price, which closed at $146.4 during Wednesday's session. A press release (AMD Reports First Quarter 2024 Financial Results) was released yesterday. |
| JCI | -7.28% | JOHNSON CONTROLS INTERNATION's (NYSE:JCI) stock price encountered a 7.28% decline, reaching $60.33 during Wednesday's session. yesterday the company released their earnings. In the last 6 months the stock gained 26.4%. |
For the full top loser list go to our top losers page.
PFIZER INC
NYSE:PFE (5/31/2024, 7:04:00 PM)
After market: 28.74 +0.08 (+0.28%)28.66
+0.46 (+1.63%)
PFE News
10 hours ago - InvestorPlace3 Discounted Stocks Poised for a Major UpswingExplore discounted upswing stocks with strong financials and strategic advantages heading for a rebound soon.
11 hours ago - InvestorPlaceBlue-Chip Blunders: 7 Stocks to Sell as Management Missteps MountSometimes top companies make bottom-shelf decisions; such is the case with these seven blue-chip stocks to sell.
a day ago - The Motley Fool3 Stocks to Buy for Huge IncomeAll 3 of these stocks have a yield above 5%.
a day ago - Pfizer Inc.Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
a day ago - Takeda Pharmaceutical Company LimitedTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
2 days ago - The Motley FoolIs Pfizer the Best Dividend Stock for You?Short-term expectation worries have elevated Pfizer's dividend yield.
Pfizer Reports Encouraging Long-Term Trial Results of Advanced Lung Cancer Drug
2 days ago - Investor's Business DailyModerna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSKModerna's RSV vaccine will launch a year behind Pfizer and GSK, but it could become the market leader over the next five years.
2 days ago - Zacks Investment ResearchPfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
2 days ago - CNBCFDA approves Moderna's RSV vaccine for seniors, the company's second-ever productThe decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its only commercially available product.
2 days ago - BusinessInsiderQUALCOMM To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
2 days ago - QuartzPfizer sees blockbuster potential for lung cancer drug Lorbrena after strong new data from phase 3 trialPfizer Chief Oncology Officer Chris Boshoff said the drug could reach $1 billion in annual sales by 2030
